Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Japan Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20063
20072
20082
20097
20103
20122
20143
20151
20161
20171
20181
20201
20214
20221
20231
20245
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated4
Recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Novo Nordisk A/S7
Kyowa Kirin Co., Ltd.4
Daiichi Sankyo Co., Ltd.3
Eli Lilly and Company3
Amgen2
Bayer2
Boehringer Ingelheim2
GlaxoSmithKline2
Takeda2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 244
Diabetes Mellitus9
Renal Insufficiency, Chronic9
Obesity5
Diabetic Nephropathies3
Glucose Metabolism Disorders2
Metabolic Diseases2
Overweight2
Atherosclerosis1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.